Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endotoxin neutralizing peptides.

Roman Jerala1, Massimo Porro

  • 1Laboratory of Biotechnology, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia. roman.jerala@ki.si

Current Topics in Medicinal Chemistry
|July 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small RNAs, big potential: Engineering microRNA-based synthetic gene circuits.

Current opinion in chemical biology·2026
Same author

Repurposing nuclear receptors for ligand-responsive liquid condensate formation and gene regulation.

Nature communications·2026
Same author

Self-assembling protein cages: from coiled-coil module to machine learning-driven <i>de novo</i> design of next-generation biomaterials.

Materials advances·2025
Same author

RNA <i>trans</i>-splicing to rescue β-catenin: A novel approach for treating CTNNB1-Haploinsufficiency disorder.

Molecular therapy. Nucleic acids·2025
Same author

Engineering chimeric PCSK9 for a vaccine against atherosclerosis.

Molecular therapy. Methods & clinical development·2025
Same author

Genotypic, functional, and phenotypic characterization in CTNNB1 neurodevelopmental syndrome.

HGG advances·2025
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026
Same journal

Mechanism of Huangqishihu Decoction in Treating Liver Fibrosis in Rats Model via Regulation of Oxidative Stress and Nrf2 Signaling Pathway.

Current topics in medicinal chemistry·2026
See all related articles

Neutralizing bacterial lipopolysaccharide (LPS) is crucial for treating gram-negative sepsis. Researchers are developing safer, novel peptides to neutralize LPS, but clinical applications are still pending.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Gram-negative sepsis progression is linked to bacterial lipopolysaccharide (LPS).
  • Host defense peptides can neutralize LPS, but this activity is separate from their antimicrobial function.
  • Polymyxin B, a potent LPS neutralizer, has toxicity limitations, restricting its use.

Purpose of the Study:

  • To review various peptide fold motifs and engineered peptides for LPS neutralization.
  • To explore novel endotoxin-neutralizing compounds and their potential medical applications.

Main Methods:

  • Review of literature on endogenous and synthetic anti-endotoxin peptides.
  • Analysis of different peptide conformations (alpha-helical, beta-hairpin, extended, compact) in LPS neutralization.

Related Experiment Videos

  • Examination of recent developments in modified peptides and non-peptidic molecules.

    • Main Results:

    • Numerous peptides show in vitro and in vivo endotoxin-neutralizing activity in animal models.
    • Various peptide structures, including alpha-helical and beta-hairpin, can neutralize LPS.
    • No LPS-neutralizing peptides have yet gained clinical approval for anti-endotoxin indications.

    Conclusions:

    • Development of novel, less toxic LPS-neutralizing peptides is ongoing.
    • Emerging strategies include modified peptides, lipopolyamines, and applications in extracorporeal removal and vaccines.
    • Further research is needed to translate preclinical findings into approved clinical therapies.